SavedAdd your journal

Journals / İstanbul Kuzey Klinikleri / 2018 / Cilt: 5 - Sayı: 2

Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study

Emin ÖZLÜ
Mümtaz TAKIR
Necmettin AKDENİZ
Ayşe Serap KARADAĞ
Tuğba Kevser UZUNÇAKMAK
Pages
114–119
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although hirsutism was more frequently observedin the nondiabetic obese group than in the diabetic obese group, stasis dermatitis was less frequently observed (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Obesity is known to be a risk factor for many diseases including dermatological problems.
📊
Key Findings & Data:Here, we aimedto determine the cutaneous manifestations in obese patients and the frequency of the accompanying dermatoses and toinvestigate the effect of diabetes mellitus in obese patients on cutaneous manifestations compared with the control group.METHODS: Our study included a total of 600 adults: 450 obese volunteers and 150 healthy volunteers.
💡
Conclusion & Impact:Although hirsutism was more frequently observedin the nondiabetic obese group than in the diabetic obese group, stasis dermatitis was less frequently observed (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Obesity is known to be a risk factor for many diseases including dermatological problems. Here, we aimedto determine the cutaneous manifestations in obese patients and the frequency of the accompanying dermatoses and toinvestigate the effect of diabetes mellitus in obese patients on cutaneous manifestations compared with the control group.METHODS: Our study included a total of 600 adults: 450 obese volunteers and 150 healthy volunteers. The number of diabeticobese patients was 138 (30%), whereas that of nondiabetic obese patients was 312 (70%). A detailed dermatologicalexamination was performed for each case, and accompanying dermatoses were compared.RESULTS: The mean body mass index (BMI) in the obese patients and control group was 37.22 kg/m2 and 22.23 kg/m2,respectively. The most common dermatoses in the obese patients were, according to their frequency: striae distensae (291patients, 64.7%), acrochordon (236 patients, 52.4%), acanthosis nigricans (213 patients, 47.3%), plantar hyperkeratosis(209 patients, 46.4%), and venous insufficiency (202 patients, 44.9%). Although hirsutism was more frequently observedin the nondiabetic obese group than in the diabetic obese group, stasis dermatitis was less frequently observed (p

🔖

Cite This Article

ÖZLÜ, E., TAKIR, M., AKDENİZ, N., KARADAĞ, A. S., UZUNÇAKMAK, T. K. (2022). Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study. İstanbul Kuzey Klinikleri, Cilt: 5 - Sayı: 2, 114–119. https://ajindex.com/articles/652034

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 2007;56:901–16.
  2. Gültekin T, Ozer BK, Akin G, Bektaş Y, Sağir M, Güleç E. Prevalence of overweight and obesity in Turkish adults. Anthropol Anz 2009;67:205–12.
  3. Lenz M, Richter T, Mühlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009;106:641–8.
  4. Kaya Erdoğan H, Gökdemir G, Purisa S, Kıvanç Altunay İ. Evaluation of Skin Findings in Adult Obese Dermatology Outpatients. TURKDERM 2011;45:184–7.
  5. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes 2012;4:68–76. American Diabetes Association. Standards of Medical Care in Diabetes— 2015. Diabetes Care 2015;38:S1–90. Nazik H, Kökçam İ, Demir B, Çoban Gül F. Skin findings in overweight and obese individuals. Turkderm - Arch Turk Dermatol Venerology 2016;50:59–64. Scheinfeld NS. Obesity and dermatology. Clin Dermatol 2004;22:303– 9. Boza JC, Trindade EN, Peruzzo J, Sachett L, Rech L, Cestari TF. Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol 2012;26:1220–3. Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005;6:165–73.
  6. Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am 2013;42:869–98.
  7. Rasi A, Soltani-Arabshahi R, Shahbazi N. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study. Int J Dermatol 2007;46:1155–9. García-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, Villa AR, Dalman JJ, Ortiz-Pedroza G. Dermatoses in 156 obese adults. Obes Res 1999;7:299–302.
  8. Sadeghian G, Ziaie H, Amini M, Ali Nilfroushzadeh M. Evaluation of insulin resistance in obese women with and without acanthosis nigricans. J Dermatol 2009;36:209–12.
  9. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992;128:941–4.
  10. Dassanayake AS, Kasturiratne A, Niriella MA, Kalubovila U, Rajindrajith S, de Silva AP, et al. Prevalence of Acanthosis Nigricans in an urban population in Sri Lanka and its utility to detect metabolic syndrome. BMC Res Notes 2011;4:25. Codner E, Iñíguez G, López P, Mujica V, Eyzaguirre FC, Asenjo S, et al. Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. Horm Res Paediatr 2013;80:343–9.